Better The Next OpenDoor?

Today’s Rip: Jackson picks BETR, Nvidia climbs on $100B chip buy, Tylenol in the crosshairs, and more. 📰

CLOSING BELL
Better The Next OpenDoor?

The market climbed to fresh all-time highs Monday, though just the tech sector gained on the S&P 500. AI tech investment kept prices moving, but only within the who‘s who club of AI giants like Nvidia and Oracle.

Tylenol maker Kenvue fell to all-time lows at the close, in the build-up to a White House speech from President Trump, where he said he will direct the NIH to warn that prenatal use of the painkiller causes Autism.

Jimmy Kimmel is set to return to his talk show seat on Tuesday, following petitions from media figures, call-outs from Republicans and Democrats, and a 3% drop in stock price for ABC owner Disney. The comedian was kicked to the curb last week for speaking about the GOP reaction to Charlie Kirk’s assassination. Opponents to Kimmel’s suspension were worried that direct threats from the FCC over Kimmel's comments were an overreach of free speech.

Today’s Rip: Is BETR the next OPEN, Nvidia climbs on $100B chip buy, Tylenol in the crosshairs, and more. 📰

1 of 11 sectors closed green, with tech $XLK ( ▲ 1.47% ) leading and staples $XLP ( ▼ 1.12% ) lagging.

MEME STOCK NEWS
Better Looks Better Than OpenDoor For Fans Of Jackson’s Memes 🏘️ 

Better Home & Finance $BETR ( ▲ 46.61% ) flew like the next OpenDoor after hedge fund manager Eric Jackson made the small New York mortgage company his next stock pick.

Posting on X, Jackson said his company EMJ Capital, bought a stake in the company and called it the “Shopify of mortgages.” On a mission to find 100-bagger stocks, Jackson helped push the $OPEN ( ▼ 12.44% ) meme run with a Twitter post in July that sent the struggling iBuying stock climbing from $1/share to nearly $10, a 1,118% climb.

Jackson said the stock could be worth upwards of nearly $12k/share in just a couple of years.

BETR was on a tear, doubling in price intraday, which is no small feat for a stock trading at $34/share on Friday. The stock was trending at the top of the Stocktwits community. Users are ‘extremely bullish’ on the stock.

STOCKS
Nvidia Climbs On OpenAI Chip Buyout 🖥️ 

Nvidia shares $NVDA ( ▲ 3.93% ) climbed nearly 4% in Monday’s session, hitting an all-time high, after the company announced that it will invest up to $100 billion in OpenAI as part of a new partnership with the AI startup.

Nvidia will supply and finance at least 10 gigawatts of advanced computing systems for the development of OpenAI’s next-generation AI models. Chief Jensen Huang told CNBC that 10 gigawatts is about 4-5M Nvidia GPUs, or roughly matching what Nvidia is on track to ship this year.

It was yet another record day for Nvidia.

A general view of Nvidia headquarters is seen in Shanghai, China, on May 19, 2025, as Nvidia plans further investment for the Shanghai research center. (Photo by Ying Tang/NurPhoto via Getty Images)

STOCKTWITS COMMUNITY EVENTS
Markets & Sports Collide At An Exclusive Event! ⚽️ 

Stocktwits is teaming up with the CMT Association to host a "Markets & Soccer Match Day" event at the iconic Sports Illustrated Stadium on Saturday, October 4th.

Hear from market legends John Roque of 22V Research and Todd Sohn of Strategas before enjoying a VIP soccer experience, including an on-field photo, guided stadium tour, and access to the VIP Audi Club with complementary food & beverage throughout the New York Red Bulls vs. FC Cincinnati game.

Only 30 tickets remain, so click here to register now! 🎟️ 

STOCKS
Kenvue Falls On Presidential Tylenol Call Out 💊 

Bloomberg TV

Kenvue Tylenol shares hit a record low, as media reports if an incoming after-market close press conference from the Trump Admin, poised to link Tylenol and Autism.

Sure enough, after $KVUE ( ▼ 7.47% ) hit a low of $16.88/share, Trump took the podium in the White House to say he was recommending people not take Tylenol, and ‘felt’ mRNA vaccines were harmful when given to babies in large amounts.

Secretary of Health and Human Services RFK Jr. took the stand to say the NIH has found connections between prenatal use of acetaminophen and Autism and ADHD. RFK Jr. drinks raw milk and has admitted that doctors found a dead worm in his brain. 🪱 

Acetaminophen has been a drug used for fever management since the end of the 1800s, and has been found to be a remarkably safe drug, becoming a popular painkiller alternative in the 1950s. It is one of the only recommended drugs for pregnant women to take for fever management. More shocking than the grounds the admin is using to target acetaminophen is that the admin is targeting a name-brand specifically.

The Washington Post wrote on Friday that RFK Jr., given the keys to ‘go wild’ with the goal of Make America Healthy again, has pushed the National Institutes of Health (NIH) to find anything they can about Autism. According to the NIH, more recent generations have higher rates of Autism, from 1 in 1,000 in 1990, to 7 in 1,000 in 2008. The RFK Jr.-led CDC now puts that figure at 1 in 31 children.

The findings were based on a Mt. Sinai Hospital meta study of 46 studies, which found “Evidence of associations between prenatal exposure to acetaminophen during pregnancy and offspring with NDDs, including ASD and ADHD, though observational limitations preclude definitive causation.”

The study searched phrases like “ADHD AND acetaminophen” in Google Scholar and PubMed to find studies that showed a ‘positive relationship’ between ADHD, Autism Spectrum Disorder, and the drug. Of 516 studies found, the team cut down to a lean 46 studies, then found 20 that showed relationships between acetaminophen and ADHD, and six studies that showed relationships between ASD and acetaminophen.

Read the whole study here. A Kenvue spokesperson told CNBC that after decades of research, there is no credible link between their drug and birth defects.

“We believe independent, sound science clearly shows that taking acetaminophen does not cause autism,” the spokesperson said. “We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers.”

POPS & DROPS
Top Stocktwits News Stories 🗞️ 

  • Metsera surges 60% on a $4.9B Pfizer buyout.

  • Oklo climbed 3% after breaking ground on Idaho Aurora reactor.

  • Office Depot jumped 32% on $1B Atlas Holdings buyout.

  • Quantum Computing sinks 14% on $500M share dilution.

  • TikTok confirms no U.S. equity stake in new entity.

  • Costco slips ahead of earnings report.

  • Plug Power jumped 22% on a price target hike.

  • Walmart expands home delivery to include Ozempic, insulin.

  • Applied Digital jumps 20% on $11B CoreWeave leases.

Don’t miss a story! Follow @StocktwitsNews for a live feed in real time. ✍️ 

WHAT’S ON DECK
Tomorrow’s Top Things 📋

Economic data: S&P Global PMI (9:45 AM), FOMC Member Bostic Speaks (10:00 AM), 2-Year Note Auction (1:00 PM). 📊
Pre-Market Earnings: AutoZone ($AZO). 🛏️
After-Market Earnings: Micron Technology ($MU) and Aytu BioPharma ($AYTU). 🌕️ 

Links That Don’t Suck 🌐

Get In Touch 📬

Help us deliver the best content possible by completing this brief survey. 📝

Want to see some change? Email Kevin Travers your feedback; follow him on Stocktwits.

Terms & Conditions 📝

Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍

Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋

Reply

or to participate.